Results 171 to 180 of about 229,156 (278)

Global bibliometric analysis of comorbid depression and anxiety in inflammatory bowel disease (2010-2024). [PDF]

Int J Colorectal Dis
Wang R, Jiang J, Feng S, Chang Y, Li H, Guo J.   +5 more
europepmc   +1 more source

Unravelling the Major Cardiovascular Risks of Systemic Psoriasis Medications: A Literature Systematic Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic inflammatory dermatological condition associated with an elevated risk of cardiovascular events (CVEs). Systemic therapies have transformed disease management, but their cardiovascular (CV) safety profiles remain incompletely understood and inconsistently reported.
Mai Thi Hoai Son, Yves Julien Mbama Biloa, Pauline Gouttefarde, Thomas Franck, Gilles Cizeron, Mathieu Oriol, François Maccari, Elisa Cinotti, Beatrice Trombert‐Paviot, Bienvenu Bongue, Jean‐Luc Perrot   +10 more
wiley   +1 more source

Limited willingness to switch from intravenous to subcutaneous treatment in paediatric inflammatory bowel disease. [PDF]

BMJ Paediatr Open
Eindor-Abarbanel A, Shalem T, Badalov O, Weiss B, Cohen DL, Shalev R, Yerushalmi B, Yerushalmy-Feler A, Topf Olivestone C, Shirin H, Broide E, Richter V.   +11 more
europepmc   +1 more source

Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel Disease. [PDF]

Int J Mol Sci
Frascatani R, Mattogno A, Salvatori S, Iannucci A, Marafini I, Monteleone G.   +5 more
europepmc   +1 more source

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru, Nesrine Brahimi, Haleh Zabihi, Cathryn Sibbald, Kyle Seigel, Delaram Shojaei, Eric McMullen, Afsaneh Alavi, Lily Archaempong, Aaron M. Drucker, Adam Weizman, Kenneth Croitoru, Robert Inman, Vincent Piguet   +13 more
wiley   +1 more source

MicroRNA‑microbiome cross‑kingdom networks drive inflammatory bowel disease through dynamic regulatory ecosystems (Review). [PDF]

Int J Mol Med
Liang L, Liu X, Li B, Lei H, Tang Z, Mai S, Yang C, Zhou Y, Zhang S, Liu L.   +9 more
europepmc   +1 more source

Serum and Fecal Calprotectin Levels Do Not Alter Significantly in Patients With Psoriasis Switching to Brodalumab After Loss of Effect From TNF‐α Inhibitors

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic inflammatory skin disease often associated with systemic conditions like psoriatic arthritis and inflammatory bowel disease (IBD). Calprotectin, an inflammatory biomarker commonly used in IBD, has also been found elevated in psoriasis.
Admir Vižlin, Hans‐Peter Claesson, Ylva Andersch Björkman, Martin Gillstedt, Eva Klingberg, Emanuela Micu, Amra Osmančević   +6 more
wiley   +1 more source

Spatial single-cell multiomics reveals peripheral immune dysfunction in Parkinson's and inflammatory bowel disease. [PDF]

NPJ Parkinsons Dis
Bolen ML, Buendia M, Shi J, Staley H, Kachergus JM, Efron PA, Park G, Nagpal R, Alvarez SD, Xue QS, McFarland NR, Zimmermann EM, Forsmark CE, Menees KB, Salas A, Aubrey Thompson E, Tansey MG.   +16 more
europepmc   +1 more source

New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa

JEADV Clinical Practice, EarlyView.
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender, Rosalind Hughes, Brian Kirby   +2 more
wiley   +1 more source

Co-Occurrence of Inflammatory Bowel Disease in Patients with Vitiligo: A Systematic Review and Meta-Analysis. [PDF]

Turk J Gastroenterol
Gu Z, Teng J.
europepmc   +1 more source